Genetic analysis of Down syndrome facilitated by mouse chromosome engineering.

Li Zhang,Dawei Fu,Pavel V Belichenko,Chunhong Liu,Alexander M Kleschevnikov,Annie Pao,Ping Liang,Steven J Clapcote,William C Mobley,Y Eugene Yu
DOI: https://doi.org/10.4161/bbug.3.1.17696
2012-01-01
Bioengineered
Abstract:Human trisomy 21 is the most frequent live-born human aneuploidy and causes a constellation of disease phenotypes classified as Down syndrome, which include heart defects, myeloproliferative disorder, cognitive disabilities and Alzheimer-type neurodegeneration. Because these phenotypes are associated with an extra copy of a human chromosome, the genetic analysis of Down syndrome has been a major challenge. To complement human genetic approaches, mouse models have been generated and analyzed based on evolutionary conservation between the human and mouse genomes. These efforts have been greatly facilitated by Cre/loxP-mediated mouse chromosome engineering, which may result in the establishment of minimal critical genomic regions and eventually new dosage-sensitive genes associated with Down syndrome phenotypes. The success in genetic analysis of Down syndrome will further enhance our understanding of this disorder and lead to better strategies in developing effective therapeutic interventions.
What problem does this paper attempt to address?